Sort by: Latest openings
forgebiologics.com
forgebiologics.com • Columbus, United States • APIs & Drug Manufacturing • Cell & Gene Therapy • 201-500 employees • Founded 2020 • Startup • Series B $120M · 5 yr ago • Xontogeny · RA Capital Management +2 • Hiring now · 1 of 14
Forge Biologics is accelerating gene therapy manufacturing: high-yield AAV manufacturing, a world-class cGMP facility, and seamless support.
Timothy Miller · Executive Officer, Director · decision-maker · no contact
Matthew Hammond · Director · no contact
Molly Bonakdarpour · Director · no contact
Frederick Callori · Director · no contact
Careers mailbox is known
Sep 28 Associate Scientist II, AD crossed 45 days open Sep 26 Technician I, GMP Manufacturing Support - Buffers (3rd Shift) crossed 45 days open Sep 25 Closed a role Senior Associate Scientist, Scientific Writing · Manager, Document Control (QA Operations) crossed 45 days open Sep 23 Closed 2 roles Statistician (Scientist I), Associate Scientist I, Process Development Downstream
14 open closes in 26 d market 25
Board re-checked 4 hours ago · 12 events in 14 days
Follow
14 roles
···
vivosense.com
vivosense.com • Data & Analytics • Health Care • 51-200 employees • Startup • New • Venture round $25M · 4 yr ago • Xontogeny
VivoSense is the wearable sensor CRO for clinical trials, delivering digital endpoint infrastructure, scientific expertise, and end-to-end DHT services.
Colin Bower · Executive Officer, Director · decision-maker · no contact
Ralf Hempfling · Director · decision-maker · no contact
Douglas McAllister · Director · decision-maker · no contact
David Hankey · Executive Officer, Director · decision-maker · no contact
Careers mailbox is known
Sep 25 Moved to Greenhouse
Board re-checked 2 min ago · 1 event in 14 days
Follow
···
tellustherapeutics.com
tellustherapeutics.com • Hillsborough, United States +1 offices • Cell & Gene Therapy • Biotechnology • 51-200 employees • Founded 2018 • Startup • New • Venture round $16M · 3 yr ago • Xontogeny
Transforming Care Within and Beyond the NICU. Tellus Therapeutics was founded on a singular mission: to bring hope and healing to the most vulnerable patients – premature infants facing life-altering brain and gut injuries with no treatment options.
Jason Kralic · Executive Officer, Director · decision-maker · no contact
Eric Benner · Executive Officer, Director · decision-maker · no contact
Jason Karlic · Executive Officer, Director · decision-maker · no contact
Chris Garabedian · Director · no contact
Careers mailbox is known
Follow
···
surf.bio
surf.bio • Biotechnology • Startup • New • Seed $16M · 4 yr ago • Xontogeny
Surf Bio is leveraging a novel biotechnology platform to develop enhanced therapeutic solutions for Diabetes, Oncology, HIV, COVID-19, and other therapeutic areas.
No named decision-maker yet.
Careers mailbox is known
Follow
···
peroxitech.com
peroxitech.com • 1-10 employees • Startup • New • Series A $25M · 3 yr ago • Xontogeny
Peroxitech is a privately held emerging biopharmaceutical company focused on the development and commercialization of a novel peptide for treating acute lung injury.
No named decision-maker yet.
No careers mailbox known
Follow
···
neurosterix.com
neurosterix.com • Financial Services • Biotechnology • 51-200 employees • Founded 2024 • Likely startup • New • Xontogeny
Harnessing the power of allosteric modulators to design targeted, next-generation therapies for complex neuropsychiatric disorders.
No named decision-maker yet.
Careers mailbox is known
Follow
···
nephrodi.com
nephrodi.com • Rare Disease Therapeutics • Biotechnology • 1-10 employees • Startup • New • Xontogeny · Sound Bioventures
About Us NephroDI Therapeutics is developing a novel AMPK activator as a first-in-class potential therapy for Nephrogenic Diabetes Insipidus (NDI). The genesis of this technology began with Drs.
No named decision-maker yet.
Careers mailbox is known
Follow
···
meridabio.com
meridabio.com • Science & Engineering • Biotechnology • Founded 2021 • Startup • New • Xontogeny
Precision therapy for autoimmune-driven diseases is now within reach. Current treatments for autoimmune diseases are non-specific, often have poor efficacy and come with a risk of serious side effects.
No named decision-maker yet.
Careers mailbox is known
Follow
···
cerevasc.com • Auburndale, United States • 51-200 employees • Founded 2020 • Startup • New • Venture round $11.1M · 6 yr ago • Xontogeny
The CereVasc eShunt® device is intended to improve patient outcomes and redefine the treatment of communicating hydrocephalus.
Leslie Teso-Lichtman · Executive Officer · decision-maker · no contact
Daniel Levangie · Executive Officer, Director · decision-maker · no contact
Aaron Levangie · Executive Officer · decision-maker · no contact
Carl Heilman · Director · no contact
No careers mailbox known
Follow
···
asclepix.com
asclepix.com • Sports Betting • Gaming • Startup • New • Xontogeny
Join Ricky Casino in Australia. Create an account, explore casino games and sportsbook, use secure payment methods and access the platform on mobile or desktop.
No named decision-maker yet.
No careers mailbox known
Follow
···
adaptilens.com
adaptilens.com • Chestnut Hill, United States • Ophthalmology & Eye Clinics • 51-200 employees • Founded 2019 • Startup • New • Series A $17.5M · 2 yr ago • Xontogeny · Pillar VC
The Adaptilens A-IOL recaptures the eye’s ability to accommodate by responding to its natural signal to focus without spectacle dependence.
Liane Clamen · Executive Officer, Director · decision-maker · no contact
C. Gianna Luca · Director · no contact
Jamie Goldstein · Director · no contact
Robert Doris · Director · no contact
Careers mailbox is known
Follow
···
galvanizetx.com • Redwood City • Health & Medical Electronics • Property & Casualty Insurance • 501-1000 employees • Startup • New • Xontogeny · Apple Tree Partners +1 • Hiring now · 1 of 9
Galvanize Therapeutics designs pulsed electric field energy devices for the surgical ablation of soft tissue, engineered to work with the body's biology.
No named decision-maker yet.
Careers mailbox is known
Sep 28 Senior Service Engineer crossed 90 days open Sep 25 Posted 9 roles Sr. Manager FP&A, Commercial & Operations, Sr. FP&A Manager, Corporate Finance
9 open $167k stated pay, 7 roles
Board re-checked 9 hours ago · 11 events in 14 days
Follow
9 roles
···
delve.bio
delve.bio • Health Care • Startup • New • Xontogeny
Delve Bio leverages mNGS to empower labs and clinicians with the results they need to diagnose routine and rare infectious diseases.
No named decision-maker yet.
No careers mailbox known
Follow
···
apogeetherapeutics.com
apogeetherapeutics.com • San Francisco, United States +1 offices • Immunology & Inflammation Therapeutics • Biologics & Biosimilars • 11-50 employees • Founded 2022 • Startup • New • Xontogeny
ApogeeTherapeutics. Apogee is seeking to reshape the current standard of care for inflammatory and immune diseases because we believe people living with these diseases deserve the best possible treatment.
No named decision-maker yet.
Careers mailbox is known
Sep 15 Moved to Greenhouse
Board re-checked 11 hours ago · 1 event in 14 days
Follow
···
aalphabio.com
aalphabio.com • Seattle, United States • Machine Learning • Biotechnology • 51-200 employees • Founded 2017 • Startup • New • Venture round $20.3M · 5 yr ago • Xontogeny · Madrona • Hiring now · 1 of 2
MEASURING, PREDICTING, ANDENGINEERING PROTEIN INTERACTIONS at Scale. A-Alpha Bio harnesses synthetic biology and machine learning to precisely engineer high-impact medicines.
David Younger · Executive Officer, Director · decision-maker · no contact
Matt McIlwain · Director · no contact
Randolph Lopez Barrezueta · Director · no contact
Ben Askew · Director · no contact
Careers mailbox is known
Sep 26 Closed a role Manager, Information Security & Technology Sep 25 Posted 3 roles Manager, Information Security & Technology, Senior Account Executive, West Coast & APAC
2 open $196k stated pay, 2 roles
Board re-checked 4 hours ago · 5 events in 14 days
Follow
2 roles
···